Related Experiment Videos
Calcium channel blockers in systemic hypertension
W H Frishman1, J A Stroh, S Greenberg
1Albert Einstein College of Medicine, Bronx, New York.
Insights
Calcium channel blockers are effective and safe treatments for systemic hypertension. These drugs are beneficial for long-term management across diverse patient groups, including those with hypertensive urgencies or co-existing conditions like angina.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Systemic hypertension pathophysiology may involve alterations in transmembrane calcium ion flux.
- Calcium channel blockers (CCBs) are recognized as effective antihypertensive agents.
Purpose of the Study:
- To review the efficacy and safety of calcium channel blockers in managing systemic hypertension.
- To highlight the applicability of CCBs in specific patient populations.
Main Methods:
- Literature review of studies on calcium channel blockers and hypertension.
- Analysis of clinical trial data regarding CCB efficacy and safety profiles.
Main Results:
- Calcium channel blockers demonstrate significant efficacy in the long-term treatment of systemic hypertension.
- These drugs possess excellent safety profiles across various patient subgroups.
- CCBs are particularly useful for hypertensive urgencies and patients with conditions like angina pectoris and arrhythmias.
Conclusions:
- Calcium channel blockers are a cornerstone therapy for systemic hypertension due to their proven efficacy and safety.
- Their broad applicability makes them suitable for a wide range of hypertensive patients, including those with complex medical histories.
Abstract:
Alterations in transmembrane flux of calcium ions may be playing a role in the pathophysiology of systemic hypertension. Calcium channel blockers have been shown to be effective antihypertensive drugs with excellent safety profiles. They are efficacious in the long term treatment of systemic hypertension in all population subgroups, and have special applicability for treating patients with hypertensive urgencies and individuals with concomitant diseases such as angina pectoris and arrhythmias.